Cite
HARVARD Citation
Samelson‐Jones, B. et al. (2021). Real‐world cost estimates of initiating emicizumab in US patients with haemophilia A. Haemophilia. 27 (4), pp. 591-598. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Samelson‐Jones, B. et al. (2021). Real‐world cost estimates of initiating emicizumab in US patients with haemophilia A. Haemophilia. 27 (4), pp. 591-598. [Online].